MeSH term
Frequency | Condition_Probility | Hereditary Sensory and Autonomic Neuropathies/*genetics | 4 | 28.0 |
Humans | 39 | 0.0 |
Mutation | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Receptor, trkA/*genetics | 12 | 85.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Animals | 12 | 0.0 |
Mice | 9 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
COS Cells | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Hypohidrosis/*genetics | 3 | 60.0 |
*Mutation | 6 | 0.0 |
Pain Insensitivity, Congenital/*genetics | 3 | 75.0 |
Transfection | 6 | 0.0 |
Infant | 5 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Male | 13 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Pedigree | 6 | 0.0 |
Adolescent | 6 | 0.0 |
Carcinoma, Papillary/*genetics | 2 | 6.0 |
Child | 8 | 0.0 |
Child, Preschool | 6 | 0.0 |
*Gene Rearrangement | 8 | 3.0 |
Neoplasms, Radiation-Induced/*genetics | 2 | 7.0 |
Thyroid Neoplasms/*genetics | 6 | 6.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Sural Nerve/pathology | 2 | 4.0 |
Exons | 5 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
*Drosophila Proteins | 6 | 0.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics | 3 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
DNA, Complementary/genetics | 5 | 0.0 |
Genotype | 2 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Female | 10 | 0.0 |
Carcinoma, Papillary/*genetics/metabolism | 2 | 22.0 |
Rats | 2 | 0.0 |
Thyroid Neoplasms/*genetics/metabolism | 2 | 12.0 |
Translocation, Genetic | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 13 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 13 | 3.0 |
Alleles | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 4 | 0.0 |
Haplotypes | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
*Accidents, Radiation | 2 | 9.0 |
Carcinoma, Papillary/*genetics/pathology | 2 | 15.0 |
Phenotype | 2 | 0.0 |
Thyroid Neoplasms/*genetics/pathology | 2 | 6.0 |
Time Factors | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Receptor, trkA | 15 | 26.0 |
Receptors, Nerve Growth Factor/*genetics | 11 | 35.0 |
Base Sequence | 15 | 0.0 |
DNA Primers | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Adult | 5 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Oncogenes | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Receptor, Ciliary Neurotrophic Factor | 2 | 2.0 |
3T3 Cells | 4 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
*Oncogenes | 2 | 0.0 |
Tropomyosin/*genetics | 2 | 11.0 |
Receptors, Nerve Growth Factor/genetics | 2 | 12.0 |
